ArticleCancers2020

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study.

Thomas Brodowicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.